Use of psychotropic medications during pregnancy: Perception of teratogenic risk among physicians in two Latin American countries

Revista Brasileira de Psiquiatria

Volumn 36, Issue 2, 2014, Pages 106-110

  Cantilino, Amaury ^a   Lorenzo, Laura ^b   de Paula, Juliane dos A ^a,c   Einarson, Adrienne ^d  

^a FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^b Psinapsys Psychiatric Private Center   (Argentina)

^c The Hospital for Sick Children ^*

^d HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Perception; Pregnancy; Psychotropic drugs; Teratogens

Indexed keywords

ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; BENZODIAZEPINE; CORTICOSTEROID; NEUROLEPTIC AGENT; PSYCHOTROPIC AGENT;

ADULT; ARTICLE; DRUG SAFETY; FEMALE; GENERAL PRACTITIONER; HEALTH CARE; HEALTH CARE PERSONNEL; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCEPTION; PREGNANCY; PSYCHIATRIST; QUESTIONNAIRE; RISK; TERATOGENICITY;

ABNORMALITIES, DRUG-INDUCED; ADULT; ANTICONVULSANTS; ARGENTINA; BENZODIAZEPINES; BRAZIL; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; PHYSICIAN'S PRACTICE PATTERNS; PREGNANCY; PSYCHOTROPIC DRUGS; QUESTIONNAIRES; RISK FACTORS; SPECIALIZATION; TERATOGENESIS;

EID: 84901203962     PISSN: 15164446     EISSN: None     Source Type: Journal    
DOI: 10.1590/1516-4446-2013-1221     Document Type: Article

References (13)

1. Bonari L, Koren G, Einarson TR, Jasper JD, Taddio A, Einarson A. Use of antidepressants by pregnant women: evaluation of perception of risk, efficacy of evidence based counseling and determinants of decision making. Arch Womens Mental Health. 2005;8:214-20.
2. Einarson A, Mazzieri MR, Sola NH, Uema S, Einarson TR. Evidence based information on drug use during pregnancy: assessment of community pharmacist in Cordoba, Argentina. Pharm Care Esp. 2002;4;209-21.
3. Lyszkiewicz DA, Gerichhausen S, Björnsdóttir I, Einarson TR, Koren G, Einarson A. Evidence based information on drug use during pregnancy: a survey of community pharmacists in three countries. Pharm World Sci. 2001;23:76-81.
4. Bilszta JL, Tsuchiya S, Han K, Buist AE, Einarson A. Primary care physician's attitudes and practices regarding antidepressant use during pregnancy: a survey of two countries. Arch Womens Ment Health. 2011;14:71-5.
5. Mulder E, Davis A, Gawley L, Bowen A, Einarson A. Negative impact of non-evidence-based information received by women taking antidepressants during pregnancy from health care providers and others. J Obstet Gynaecol Can. 2012;34:66-71.
6. National Collaborating Centre for Mental Health. Antenatal and postnatal mental health: the NICE guideline on clinical management and service guidance. Leicester: British Psychological Society; 2007.
7. American Psychiatric Association. Practice guideline for the treatment of patients with major depressive disorder [Internet]. 3th edition. [cited 2013 Apr 27]. http://psychiatryonline.org/content. aspx?bookid=28§ionid=1667485#654024.
8. Finer LB, Zolna MR. Unintended pregnancy in the United States: incidence and disparities. Contraception. 2011;84:478-85.
9. Galbally M, Roberts M, Buist A, Perinatal Psychotropic Review Group. Mood stabilizers in pregnancy: a systematic review. Aust N Z J Psychiatry. 2010;44:967-77.
10. Einarson A, Boskovic R. Use and safety of antipsychotic drugs during pregnancy. J Psychiatr Pract. 2009;15:183-92.
11. Enato E, Moretti M, Koren G. The fetal safety of benzodiazepines: an updated meta-analysis. J Obstet Gynaecol Can. 2011;33:46-8.
12. Dolovich LR, Addis A, Vaillancourt JM, Power JD, Koren G, Einarson TR. Benzodiazepine use in pregnancy and major malformations of oral cleft: meta-analysis of cohort and case-control studies. BMJ. 1998;317:839-43.
13. Byatt N, Deligiannidis KM, Freeman MP. Antidepressant use in pregnancy: a critical review focused on risks and controversies. Acta Psychiatr Scand. 2013;127:94-114.